Results 91 to 100 of about 6,688 (239)

Guillain‐Barré syndrome: a comprehensive review

European Journal of Neurology, Volume 31, Issue 8, August 2024.
Abstract Guillain‐Barré syndrome (GBS) is a potentially devastating yet treatable disorder. A classically postinfectious, immune‐mediated, monophasic polyradiculoneuropathy, it is the leading global cause of acquired neuromuscular paralysis. In most cases, the immunopathological process driving nerve injury is ill‐defined.
Roberto Bellanti, Simon Rinaldi
wiley   +1 more source

An update on myasthenia gravis [PDF]

, 2000
Myasthenia gravis (MG) is an autoimmune disease characterised by autoantibodies against acetylcholine receptors at neuromuscular junctions, resulting in defective neuromuscular transmission.
Chan, KH, Ho, SL
core  

NMR‐based metabolomic investigation of dogs with acute flaccid paralysis due to tick paralysis

Veterinary Medicine and Science, Volume 10, Issue 4, July 2024.
The NMR‐based serum metabolomics approach used in this study revealed distinct up‐regulated/down‐regulated expressions, presenting a promising avenue for research. It was observed that energy metabolism, particularly liver function, was impaired in dogs with tick paralysis.
Erdem Gülersoy, Canberk Balıkçı, Adem Şahan, İsmail Günal, Mehmet Osman Atlı   +4 more
wiley   +1 more source

Clinical and genetic basis of congenital myasthenic syndromes

Arquivos de Neuro-Psiquiatria
Neuromuscular junction disorders represent a wide group of neurological diseases characterized by weakness, fatigability and variable degrees of appendicular, ocular and bulbar musculature involvement.
Paulo Victor Sgobbi de Souza, Gabriel Novaes de Rezende Batistella, Valéria Cavalcante Lino, Wladimir Bocca Vieira de Rezende Pinto, Marcelo Annes, Acary Souza Bulle Oliveira   +5 more
doaj   +1 more source

Coexistence of myasthenia gravis and lichen planus: A case report and systematic review of related case reports from 1971 to 2024

Clinical Case Reports, Volume 12, Issue 6, June 2024.
Key Clinical Message The co‐occurrence of myasthenia gravis (MG) and lichen planus (LP) is a rare phenomenon, with only 13 cases reported in the English literature between 1971 and 2024. Patients with MG or LP, regardless of the thymoma status, require close monitoring for other autoimmune diseases.
Melika Jameie, Mobina Amanollahi, Bahareh Ahli, Ghasem Farahmand, Hana Magrouni, Payam Sarraf   +5 more
wiley   +1 more source

Initial screening for neuronal autoantibodies and their putative impact on survival in patients with small‐cell lung cancer

Thoracic Cancer, Volume 15, Issue 17, Page 1350-1356, June 2024.
In a retrospective study, serum from patients with biopsy‐proven small‐cell lung cancer (SCLC) at the time of diagnosis was studied prior to treatment. The sera were analyzed for the presence of neuronal autoantibodies blinded to clinical status. The main finding was demonstration that neuronal autoantibodies were frequent at the time of diagnosis ...
Anne With Mikkelsen, Anna Christine Nilsson, Helene Broch Tenstad, Soeren Thue Lillevang, Nasrin Asgari   +4 more
wiley   +1 more source

Neurological autoimmunity in patients with non‐pulmonary neuroendocrine neoplasms: clinical manifestations and neural autoantibody profiles

European Journal of Neurology, Volume 31, Issue 6, June 2024.
Abstract Background and purpose Paraneoplastic neurological autoimmunity is well described with small‐cell lung cancer, but information is limited for other neuroendocrine neoplasms (NENs). Methods Adult patients with histopathologically confirmed non‐pulmonary NENs, neurological autoimmunity within 5 years of NEN diagnosis, and neural antibody testing
Georgios Mangioris, Thorvardur R. Halfdanarson, Vanda A. Lennon, Bryce K. Chang, Divyanshu Dubey, P. James B. Dyck, Eoin P. Flanagan, Andrew McKeon, John R. Mills, Sean J. Pittock, Anastasia Zekeridou   +10 more
wiley   +1 more source

Paraneoplastic neurological syndromes

Orphanet Journal of Rare Diseases, 2007
Paraneoplastic neurological syndromes (PNS) can be defined as remote effects of cancer that are not caused by the tumor and its metastasis, or by infection, ischemia or metabolic disruptions.
Antoine Jean-Christophe, Honnorat Jérôme   +1 more
doaj   +1 more source

Manifestações neurológicas como forma de apresentação do cancro do pulmão [PDF]

, 1985
O cancro do pulmão, em particular o carcinoma de pequenas células do pulmão, é a principal causa maligna de síndromes paraneoplásicas. Esta revisão foca-se nos dados da literatura acerca da associação das síndromes paraneoplásicas com o cancro do pulmão.
Pereira, Maria Armanda Laureano Simões Castro
core   +1 more source

Paraneoplastic Antibodies [PDF]

, 2016
Paraneoplastic neurological syndromes (PNS) are remote effects of cancer. These are not caused by invasion of the tumor or its metastasis nor by other direct effects of the tumor or its treatment.
Maat, P. (Peter)
core